Author: Shimrez Hyder

NanoVibronix Inc. (NAOV) stock prices were down by 6.78% as of the market closing on August 31^st 2021. This brought the price per share down to USD$2.75 at the end of the trading day. Subsequent premarket fluctuations saw the stock rise by 1.45%, bringing it up to USD$2.79.

NAOV Stock Reworks Product Portfolio

NAOV stock had a stellar first half of fiscal 2021, with the continued and accelerating progress made towards full commercialization of its products. The past quarter has seen the expansion of distribution, clearance of regulatory approvals, and the launch of PainShield Plus. The company also plans to launch its PainShield RELIEF as an over-the-counter option for patients, thereby significant expanding the company’s addressable market.

Continued Development

The company’s entire product portfolio has been redesigned, with the new version boasting improved appearance, functionality, and efficiency. NAOV stock has submitted patent applications to protect its intellectual property, in the interest of both its existing brands and technologies as well as products still in development. The company’s stellar business model is comprised of innovative products that are in the process of clearing regulatory approvals and a high-quality manufacturing partner, in conjunction with global distribution channels. The market environment itself has been exhibiting increasing demand that facilitates further growth.

Favorable Market Environment

The demand for product current exceeds the company’s supplies across all of the markets it is involved in, including commercial, insurance, and the Veterans Administration (VA). In tandem with the energy of its distributors to bring products to the market, the company finds this level of demand to reinforce optimism for continued growth. The company’s growing backlog of orders and its ongoing submissions for regulatory approval in new markets has resulted in further expansive developments. NAOV stock is actively searching for additional manufacturers for their products, as well as initiating engagements with addition contract manufacturers around the world to expand output.

NAOV Stock’s PainShield RELIEF

The company is also planning its entry into the over-the-counter market with the launch of PainShield RELIEF. RELIEF is a derivative of NAOV stock’s prescription PainShield that is expected to be available without a clinician’s prescription. The company opening and expanding availability of the pain management device to the mass market will result in the expansion of revenue potential.

Future Outlook for NAOV stock

The company reported a strong Q2 2021, evidenced by the strength of its financial reports. NAOV stock is poised to capitalize on the opportunities presented to as a result of the momentum it has generated. Current and potential investors are hopeful that management will be able to leverage the resources at their disposal. This is hoped to facilitate significant and sustained increases in shareholder value.

Supernova Partners Acquisition Company Inc. (SPNV) stock prices were down by 1.64% as of the market closing on August 31^st, 2021. This brought the price per share down to USD$8.99 at the end of the trading day. Subsequent premarket fluctuations saw the stock rise by 5.78%, bringing it up to USD$9.51.

SPNV Stock Posts First Profit

Offerpad’s performance over the second quarter of fiscal 2021 resulted in the posting of the first quarterly profit in the company’s history. The company has been penetrating the nearly USD$2 trillion U.S. residential real estate market, which is still largely fractured, time consuming, stressful, and expensive. This is at odds with consumers expecting a fast, easy, and seamless online experience when conducting a real estate transaction.

Ahead of the Competition

The company sets itself apart from its competitors with a highly adaptive and customer-centric business model. This has translated into a proven ability to grow and excel in all types of market conditions. SPNV stock’s success has been based on a combination of proprietary technology, home underwriting accuracy, and renovation excellence. The company also boasts unique expertise, combining technology development and real estate transaction experience to facilitate operating at the most efficient level in the market.

Strength of Q2 2021

The strength of Q2 2021 was largely attributable to the company’s continued focus on operational excellence in a context of favorable market conditions. SPNV stock’s strong quarter was also facilitated by the company’s ability to match the right services with the right consumers. The quarter saw particularly strong operational performance, with reports of USD$39.7 million in total contribution profit. This brings the total year to date reports for the first half of fiscal 2021 up to USD$63.2 million, already surpassing previous internal projections for the full year 2021.

SPNV Stock’s Trajectory of Success

SPNV stock continued to prove its scalability and adaptability, as evidence by the acquisition of a record 2,025 homes over Q2 2021. The quarter also saw the company complete its first 24-hour close on a home. The quarter’s results demonstrate the momentum Offerpad has generated as it executes its market penetration and expansion strategy. SPNV has started the third quarter of fiscal 2021 further setting the stage for a strong second half of fiscal 2021.

Future Outlook for SPNV Stock

The company reported a promising quarter, as evidenced by the strength of its financial reports and its first-ever quarterly profit. SPNV stock is poised to further capitalize on the opportunities presented by its recently acquired partner. Investors are hopeful that this will facilitate significant and sustained increases in shareholder value.

BEST Inc. (BEST) stock prices were up by 13.04% as of the market closing on August 31^st, 2021. This brought the price per share up to USD$1.30 at the end of the trading day. Subsequent premarket fluctuations have seen the stock up by 4.62%, bringing it down to USD$1.36.

BEST Stock’s Strategic Refocusing Plan

The second quarter of fiscal 2021 saw BEST stock report continuing the executing of their strategic refocusing plan. This will build on the promising activity seen in network stability, service quality, and cost reduction, while adapting to a changing and competitive marketspace. Fortunately, the company finds itself in a context of supportive industry regulation, as well as strong e-commerce growth. On these bases, BEST is confident that its strategic refocusing plan will position it to deliver improved operating and financial results over the upcoming quarter.

BEST Stock’s Revenue Report

The company reported revenues in the amount of  USD$1.142 billion, representing a 5% year over year decrease. This yearly difference was largely driven by a decrease in average selling price in Express and Freight business segments. This was partially offset by increases in volumes sold for both Express and Freight. Accordingly, net loss for the quarter came out to USD$72.4 million, a stark decrease from the net income of USD$6.61 million reported in the prior year quarter.

Solid Liquidity Position

BEST stock reported a stellar liquidity position at the end of the second quarter of fiscal 2021. The company reported USD$528.6 million in cash and cash equivalents, restricted cash and short term investments as of June 30^th 2021. The slight year over year decrease was largely driven by the use of net cash in financing activities.

Q2 2021 SG&A Expenses

Selling, general, and administrative costs came out to USD$71 million for the second quarter of fiscal 2021, representing 6.2% of revenue. This is comparable to the USD$62.47 million SG&A expenses reported for the prior year quarter, which came out to 5.2% of revenue. This year over year increase was largely attributable to additional bad debt provision. This provision resulted from the pandemic and the lack of certain Covid-19 pandemic related subsidies that were available in 2020.

Future Outlook for BEST Stock

The company reported a promising Q2 2021, evidenced by the strength of its financial reports for the quarter. BEST stock is keen to capitalize on the momentum it has generated, with hopes to sustain it through the upcoming quarter. Investors are confident that this will result in organic increases in shareholder value over the long term.

American Woodmark Corp. (AMWD) stock prices were down by 12.67% some time after market trading commenced on August 31^st, 2021. This brought the price per share down to USD$70.21 early on in the trading day.

AMWD Stock’s Net Sales Reports

The first quarter of fiscal 2022 saw AMWD stock report net sales in the amount of USD$442.6 million. This is a 13.5% increase from the numbers reported for the prior-year quarter. The company reported growth across all of its channels as compared to the prior-year quarter. The repair and remodel sales channel reported growth in the high-teens, while the construction sales channel reported growth in the upper single digits. The year-over-year improvements were largely driven by the growth in market demand at a promising pace.

Net Income Reports

Net income came out to USD$3 million for Q1 2022, representing a net income of USD$0.18 per diluted share. This is compared to the USD$16.1 million reported in the prior-year quarter, representing a net income of USD$0.94 per diluted share. The year-over-year difference was largely attributable to the rapidly evolving inflationary pressures that outpaced the pricing actions undertaken across all of the company’s channels. This translated into 220 basis points of sequential pressure from Q4 2021 to Q1 2022, primarily related to materials and logistics costs.

AMWD Stock’s Liquidity Position

AMWD stock reported a solid liquidity position as of the end of the first quarter of 2022. As of July 31^st 2021, the company reported USD$27.8 million in cash on hand, with additional access to USD$243 million under its revolving credit facility. The company does not have any term loan debt maturities until July 2023, but has paid down USD$29.1 million of its existing debt. The first quarter of 2022 also saw the company repurchase shares valued at USD$25 million.

Continued Trajectory of Success

On the basis of current sales levels, the company expects the impact of confirmed pricing actions to increase in the second half of fiscal 2022 to more than USD$25 million per quarter. This consolidated the company’s focus on increasing production to match a strong demand environment.

Future Outlook for AMWD Stock

The company reported a promising quarter, as evidenced by the strength of its financial reports for Q1 2022. AMWD stock is poised to capitalize on the opportunities presented to it as a result of the momentum it has generated. Investors are confident in management’s ability to effectively leverage the resources at their disposal. This is hoped to translate into organic growth over the long term.

Chico’s FAS Inc. (CHS) stock prices were down by 14.70% shortly after market trading commenced on August 31^st, 2021. This brought the price per share down to USD$4.99 early on in the trading day.

CHS Stock’s Record Second Quarter

The company’s second-quarter 2021 earnings performance was the best second-quarter reported since 2013. This evidences CHS stock’s remarkable progress as it continues executing its turnaround strategy, despite pandemic challenges. The company’s return to profitability in Q2 2021 was driven by the execution of its strategic actions that resulted in an increase in sales and gross margin. The company’s profitability was also driven by the diligent control of their expenses.

CHS Stock’s Sales Breakdown

Sales across all three of the company’s brands were supported by substantial enhancements in product and marketing. This continued to drive full-price selling, reduce markdowns, and produce a higher gross margin. Soma reported a 53% year-over-year increase in sales, positioning it to become one of the largest intimate apparel brands in the U.S. Sales at Chico’s were up 59% over the past year, while White House Black market was up 48%. CHS stock reported overwhelmingly positive reception of its elevated styling and quality standards, which led to faster sell-through rates and higher inventory productivity.

Net Income Reports

The second quarter of fiscal 2021 saw CHS stock report net income in the amount of USD$26.2 million, representing a net income of USD$0.21 per diluted share. This is a massive improvement from the net loss of USD$46.8 million reported for the prior-year quarter, representing a net loss of USD$0.40 per diluted share. The net loss reported in the second quarter of 2020 included USD$8 million in significant after-tax non-cash inventory write-offs.

Solid Liquidity Position

CHS stock reported a solid liquidity position as of the end of the second quarter of fiscal 2021. This included cash and marketable securities totaling USD$137.2 million compared to USD$124.5 million at the end of the prior year quarter. The company reported debt in the amount of USD$149 million at the end of Q2 2021.

Future Outlook for CHS Stock

The company reported a promising quarter, as evidenced by its record-breaking second-quarter financial reports for 2021. CHS stock is poised to capitalize on the momentum it has generated as it usher in organic growth over the long term. Investors are hopeful that this will result in significant and sustained increases in shareholder value.

Mesoblast Ltd. (MESO) stock prices were down by 9.56% shortly after market trading commenced on August 31^st 2021. This brought the price per share down to USD$6.62 early on in the trading day.

MESO Stock Applies for EUA

MESO stock reported a meeting with the United States Food and Drug Administration (FDA) in regard to the potential EUA for remestemcel-L. The emergency use authorization would be for the treatment of ventilator-dependent patients with moderate or severe acute respiratory distress syndrome ARDS, arising from Covid-19. The FDA concluded that an additional clinical study in Covid-19 ARDS would be required to approve the EUA. A statistically positive outcome could provide a dataset in conjunction with the recently completed 222 patient clinical study.

Development of Remestemcel-L

The U.S FDA provided MESO stock with guidance about the existing Covid-19 ARDS Investigational New Drug (IND) file and future submissions for remestemcel-L. The existing IND may continue to cross-reference manufacturing information in Biologics License Application (BLA) 125706 for pediatric steroid-refractory acute graft versus host disease. The FDA further indicated the requirement of potency assays needing to be established and agreed upon prior to the commencement of the proposed Phase 3 clinical trial.

MESO Stock Working with FDA

The company was also informed by the FDA that existing potency assays in development seemed to be reasonable, on the basis of in vitro results provided in relevant briefing documents. The in vitro activity of the product appears to be relatively well established, despite the relationship between in vitro activity and the product’s actual mechanism of action remains theoretical. MESO stock plans to meet with the FDA’s Office of Tissue and Advanced Therapies (OTAT) in the fourth quarter of 2021. Together, they will address potency assays for remestemcel-L in relation to SR-aGvHD, with the company posting that these attributes could also be relevant to Covid-19 ARDS.

Partnership with Novartis

MESO Stock has also entered into a license and collaboration agreement with Novartis. This partnership will facilitate the development, manufacture, and commercialization of remestemcel-L, with an initial focus on the treatment of ARDS. The agreement is contingent on certain closing conditions, as well as time to analyze the results from the Covid-19 ARDS trial.

Future Outlook for MESO stock

The company reported a promising quarter, as reflected by its promising financial and operational reports for Q2 2021. MESO stock is poised to capitalize on the opportunities afforded to it in the context of a pandemic that is once again gaining traction. Current and potential investors are hopeful that management will be able to usher in organic growth over the long term.

Cano Health Inc. (CANO) stock prices were down 1.15% shortly after market trading commenced on August 31^st 2021. This brought the price per share down to USD$12.02 early on in the trading day.

CANO Stock’s Revenue and Income

The second quarter of fiscal 2021 saw CANO stock report total revenues in the amount of USD$393.2 million. This is up from the USD$171.2 million reported for the second quarter of 2020. The year over year increase was largely attributable to acquisitions and membership growth.  Net income for the 2021 quarter came out to USD$4.9 million, up from the USD$11.0 million net loss reported for the second quarter of 2020. Adjusted EBITDA for Q2 2021 came out to USD$24.8 million in the second quarter of fiscal 2021, representing a 53% increase from the USD$16.2 million reported in Q2 2020.

Covid-19 Regaining Traction

With the United States having entered into a fourth wave of the Covid-19 pandemic, Florida is experiencing a record number of new Covid-19 cases. The company observed a seven-day daily average of 14.3 cases in Cano Health members as of August 9^th, 2021. This is compared to a seven day daily average of 24.0 cases at the pandemic peak in January 2021. August 2021 has seen 7.5 Covid-19 hospital admissions per 1,000 as compared to Cano Health’s pandemic peak of 21.2 in July 2020. Covid-19 mortality among Cano Health members remains at least 50% lower than the senior population in Florida.

Medical Claims Expense Ratio

Q2 2021 reported medical claims expense ratio in the amount of 77%, up from the 73% reported for the prior quarter. This quarter over quarter difference was largely driven by the inclusion of DCE members who were expected to have higher medical costs. The difference was also supported by higher elective procedure utilization and costs related to Covid-19.

CANO Stock’s Liquidity Position

CANO stock reported USD$319 million in cash, cash equivalents, and restricted cash as of June 30^th 2021. The company concurrently reported having USD$557 million in debt. July 2^nd 2021 saw the company borrow an additional USD$250 million through an unsecured loan in connection with the purchase of DMC.

Future Outlook for CANO Stock

The company reported a promising quarter, consolidated by the strength of its financial reports from earlier in August 2021. CANO stock is poised to capitalize on the opportunities presented by the persistent Covid-19 pandemic. Investors are hopeful that management will be able to effectively leverage the resources at their disposal. This is hoped to facilitate significant and sustained increases in shareholder value.

Youdao Inc. (DAO) stock prices were up by 1.55% as of the market closing on August 30^th, 2021. This brought the price per share up to USD$10.48 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rise by 6.30%, bringing it up to USD$11.14.

DAO Stock Reports Strong Q2 2021

The second quarter of fiscal 2021 saw DAO stock launch its self-developed Intelligence Practice Systems. The platform serves to comprehensively and seamlessly integrate teaching and research with advanced technology. This is hoped to result in the quick customization of learning paths for students, thereby improving their learning outcomes. The company is also firmly committed to the fulfillment of its social responsibilities, such as providing relief in response to the recent floods in Henan Province. The company collaborated with public welfare institutions to facilitate the provision of post-disaster reconstruction and instructor support for 10 to 15 schools and kindergartens.

Adapting to Changing Regulations

The Chinese government recently released statements in regard to the further reduction of student burden in relation to homework and off-campus tutoring for compulsory education. In response, DAO stock has seen growth stem from its non-AST business, which includes learning products, STEAM courses, adult education, and education digitization solutions.While the company’s K-12 business is expected to be materially affected by heightened regulatory requirements, DAO stock is keen to adapt accordingly. With a focus on remaining compliant with regulatory requirements, the company is allocating resources to drive sustainable growth in the long run through innovative technologies and products.

DAO Stock’s Revenue Reports

Net revenues for the second quarter of fiscal 2021 came out to USD$200.3 million, representing a significant 107.5% year over year increase. Net revenues generated from learning services were up 112.4% year over year to hit USD$142.7 million in Q2 2021. The yearly difference was largely attributable to increases revenues from online courses. These increases, in turn, were driven by increases in paid student enrollments for Youdao Premium Courses. Paid student enrollment for adult courses of Youdao Premium Courses were up by 70.3%.

Future Outlook for DAO Stock

The company reported a promising quarter, consolidated by the strength of its Q2 2021 financial reports. DAO stock is keen to continue adapting to the changing Chinese economic landscape, with investors hopeful in management’s ability to effectively allocate resources. This is hoped to translate into consistent and organic growth over the long term.

Borr Drilling Ltd.’s (BORR) stock price was up by 1.13% as of the market closing on August 30^th, 2021. This brought the price per share up to USD$0.71 at the end of the trading day. Subsequent premarket fluctuations saw the stock surge by 9.75%, bringing it up to USD$0.78.

The second quarter of fiscal 2021 saw steady improvements in BORR stock’s operations. The end of the quarter marked 13 working rigs in operation. The 2021 fiscal year has seen the company reporting having received significant contracts, which have resulted in the addition of roughly USD$542 million in revenues to their backlog. The company’s fleet holds an addition ten rigs that have been delivered and can be deployed in an improving market. The fleet will also be consolidated by an additional five rigs that are yet to be delivered by the Keppel FELS shipyard.

Expansion of BORR Stock’s Fleet

The upcoming few weeks are expected to see ongoing negotiations for the operation of 17 rigs. These rigs are expected to start generating revenue by the end of the fiscal year 2021. In the current global market of elevated oil prices, rig demand is returning to pre-pandemic levels, going so far as to exceed previous highs. The global fossil fuel environment also sees the natural reduction of rig supply, which BORR stock poised to capitalize on the opportunities this presents to it. The company is keen to commence operations across all 23 of its delivered rigs by the end of 2022.

Facilitating Further Expansion

The current quarter is expected to generate positive cash from operations after the company pays off cash interest cost at the current level of 13 rigs operating at contracted rates for a full quarter. BORR stock also reported improved collections from its Mexican joint ventures, as well as the sale of its stake in IWS JVs. Resultingly, the company generated USD$42.4 million from its Mexico operations since the start of the fiscal year. With the added capital, BORR stock managed to release working capital, while concurrently securing additional work for its five rigs in the U.S until the end of 2022.

Future Outlook for BORR Stock

The company reported a promising quarter, consolidated by the strength of its financial reports for Q2 2021. BORR stock is poised to capitalize on the momentum it has generated, in tandem with favorable market conditions. Current and potential investors are hopeful for significant and sustained increases in shareholder value.

Lowe’s Companies Inc. (LOW) stock prices were down 0.44% as of the market closing on August 30^th 2021. This brought the price per share down to USD$204.99 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rise by 0.20%, bringing it up to USD$205.40.

LOW Stock Donates USD$2 Million

August 30^th 2021 saw the company announce the donation of USD$2 million towards supporting relief efforts from the damage caused by Hurricane Ida along the Gulf Coast. As per the announcement, LOW stock will donate USD$1 million to disaster relief partners, including the American Red Cross. This will serve to help organizations provide emergency shelter, food, relief, and rebuilding supplies and comfort to those affected by the natural disaster. The other USD$1 million is planned to be allocated towards supporting product donations.

Hurricane Ida Relief Efforts

The company has continued to serve the local communities where it has locations, with the donation further helping remedy the situation. The support to its nonprofit partners will aid the recovery and rebuilding efforts for months to come. Furthermore, the company is helping with evacuation expenses to assist associates in the hurricane’s trajectory. LOW stock will also help deploy emergency response teams, while doubling their company match through its Employee Relief Fund.

Disaster Relief Buckets

LOW stock plans to host bucket brigade events in the hardest-hit areas to distribute essential clean up supplies for free to local residents. The company has distributed nearly 2,000 disaster relief buckets across the nation in an effort to help the recovery of affected communities. These buckets were assembled over the Summer by associates at the company’s distribution centers.

LOW Stock’s Employee Assistance

The company is also allocating resources towards assisting its associates circumvent the challenges brought on by the hurricane. LOW stock has pledged up to USD$500 for associates with emergency needs related to the cost of evacuation and preparation expenses. The Lowe’s Employee Relief Fund is also being expanded in an effort to increase the scope of financial assistance available. The doubling of the company’s match will now see USD$2 for every dollar an employee donates.

Future Outlook for LOW Stock

LOW stock’s involvement in its communities reflects its core value of inclusive integration. The company is set to recover financially from the unexpected expenses incurred as a result of Hurricane Ida, with the help of the improvement of its brand image following its relief efforts. Investors are hopeful this consolidates the company’s brand loyalty and translated into organic growth over the long term.